α-neoendorphin (Human) [759]



α-neoendorphin (Human)


SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O
InChIKey KZTDMJBCZSGHOG-XJIZABAQSA-N
Sequence YGGFLRKYPK
HELM PEPTIDE1{Y.G.G.F.L.R.K.Y.P.K}$$$$

Chemical Properties

Hydrogen bond acceptors 16
Hydrogen bond donors 16
Rotatable bonds 38
Log P -1.972
Molecular weight (Da) 1227.7
Stereochemistry info unspecified

Database connections

Model (AF2) κ δ
GPCRdb related ligands

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

α-neoendorphin (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) κ δ

Compound is not listed as a drug.